Biopharma Absci Prices US$200 Million IPO

Synthetic biology company Absci Corporation began trading on the Nasdaq Global Select Market today under the symbol “ABSI”. The firm’s initial public offering is looking to raise US$200.0 million and is expected to close on July 26, 2021.

The offering consists of 12,500,000 common shares selling at US$16.00 per share. This puts the company valuation at approximately US$1.5 billion.

The company granted a 30-day over-allotment option to purchase additional 1,875,000 common shares at the same IPO price, potentially bringing total offering proceeds up to US$230.0 million. J.P. Morgan, Credit Suisse, BofA Securities, Cowen, and Stifel are all acting as joint bookrunners for the said offering.

The Washington-based biopharma company uses technology to develop the potential role of proteins in therapeutics.


Information for this briefing was found via Sedar and Absci. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Uranium Is Back On America’s Radar | Corey Dias –  Anfield Energy

The Russell Will Lead the Next Market Crash!? | John Feneck

The Global Conflict Has Already Started | Bryan Cunningham

Recommended

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Altamira Gold Encounters Porphyritic Intrusive Rocks In Initial Scout Drilling At Regional Targets

Related News

Tech SPAC 10X Capital Venture Acquisition III Prices Upsized US$261 Million IPO

Blank check company 10X Capital Venture Acquisition Corp. III (NYSE: VCXB.U) is looking to raise...

Wednesday, January 12, 2022, 02:18:00 PM

LNG Firm Excelerate Energy Launches IPO

Liquefied natural gas company Excelerate Energy is looking to go public on the New York...

Tuesday, April 5, 2022, 02:21:00 PM

Investment Management Software Enfusion Prices US$318.75 Million IPO

Accounts payable automation software Enfusion, Inc. (NYSE: ENFN) started publicly trading on the New York...

Thursday, October 21, 2021, 02:19:00 PM

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM

Shein Reportedly Filed $63 Billion London IPO Amid U.S. Regulatory Hurdles

Online fashion retailer Shein has confidentially filed papers for a potential listing in London, a...

Monday, June 24, 2024, 09:02:00 AM